...
首页> 外文期刊>Mediators of inflammation >Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Accelerates the Progression of Renal Fibrosis in Lupus Nephritis by Activating SMAD and p38 MAPK in TGF-beta 1 Signaling Pathway
【24h】

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Accelerates the Progression of Renal Fibrosis in Lupus Nephritis by Activating SMAD and p38 MAPK in TGF-beta 1 Signaling Pathway

机译:肿瘤坏死因子弱凋亡器凋亡器通过在TGF-Beta 1信号通路中激活Smad和P38 MAPK来加速狼疮肾炎中肾纤维化的进展

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study aim was to explore the effects of tumor necrosis factor-like weak inducer of apoptosis ( TWEAK) in lupus nephritis and its potential underlying mechanisms. MRL/lpr mice were used for in vivo experiments and human proximal tubular cells (HK2 cells) were used for in vitro experiments. Results showed that MRL/lpr mice treated with vehicle solution or LV-Control shRNA displayed significant proteinuria and severe renal histopathological changes. LV-TWEAK-shRNA treatment reversed these changes and decreased renal expressions of TWEAK, TGF-beta 1, p-p38 MAPK, p-Smad2, COL-1, and alpha-SMA proteins. In vitro, hTWEAK treatment upregulated the expressions of TGF-beta 1, p-p38 MAPK, p-SMAD2, alpha-SMA, and COL-1 proteins in HK2 cells and downregulated the expressions of E-cadherin protein, which were reversed by cotreatment with anti-TWEAKmAb or SB431542 treatment. These findings suggest that TWEAK may contribute to chronic renal changes and renal fibrosis by activating TGF-beta 1 signaling pathway, and phosphorylation of Smad2 and p38 MAPK proteins was also involved in this signaling pathway.
机译:该研究目的是探讨狼疮肾炎细胞凋亡(调整)的肿瘤坏死因素弱诱导剂的影响及其潜在的基础机制。 MRL / LPR小鼠用于体内实验和人近端管状细胞(HK2细胞)用于体外实验。结果表明,用载体溶液或LV-ConceptRNA处理的MRL / LPR小鼠显示出明显的蛋白尿和重度肾组织病理学变化。 LV-Tweak-shRNA治疗颠倒了这些变化,降低了调整,TGF-β1,P-P38 MapK,P-Smad2,Col-1和α-SMA蛋白的肾表达减少。在体外,Htweak治疗上调了HK2细胞中TGF-β1,P-P38MapK,P-Smad2,α-SMA和COL-1蛋白的表达,并下调了E-Cadherin蛋白的表达,其被Cotreatment逆转用抗拨排或SB431542治疗。这些发现表明,通过激活TGF-Beta 1信号通路,调整调整可能有助于慢性肾变化和肾纤维化,并且Smad2和P38 Mapk蛋白的磷酸化也参与该信号通路。

著录项

  • 来源
    《Mediators of inflammation》 |2016年第3期|共13页
  • 作者单位

    Hebei Univ Sci &

    Technol Dept Biol Sci &

    Engn Shijiazhuang 050018 Peoples R China;

    Soochow Univ Affiliated Hosp 2 Dept Rheumatol &

    Immunol Suzhou 215000 Peoples R China;

    Soochow Univ Affiliated Hosp 2 Dept Rheumatol &

    Immunol Suzhou 215000 Peoples R China;

    Soochow Univ Affiliated Hosp 2 Dept Rheumatol &

    Immunol Suzhou 215000 Peoples R China;

    Soochow Univ Affiliated Hosp 2 Dept Rheumatol &

    Immunol Suzhou 215000 Peoples R China;

    Soochow Univ Affiliated Hosp 2 Dept Rheumatol &

    Immunol Suzhou 215000 Peoples R China;

    Soochow Univ Affiliated Hosp 2 Dept Rheumatol &

    Immunol Suzhou 215000 Peoples R China;

    Soochow Univ Affiliated Hosp 2 Dept Rheumatol &

    Immunol Suzhou 215000 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 病理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号